Holen Sie sich die Stockscreener-App
64.24
1.79%
1.16
Schlusskurs vom Vortag:
$63.08
Offen:
$63.71
24-Stunden-Volumen:
359.59K
Relative Volume:
0.20
Marktkapitalisierung:
$8.04B
Einnahmen:
$12.50B
Nettoeinkommen (Verlust:
$314.00M
KGV:
26.33
EPS:
2.44
Netto-Cashflow:
$421.00M
1W Leistung:
-0.11%
1M Leistung:
-7.47%
6M Leistung:
-9.80%
1J Leistung:
-10.87%
1-Tages-Spanne:
$63.34
$64.36
1-Wochen-Bereich:
$62.40
$65.02
52-Wochen-Spanne:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Vergleichen Sie HSIC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
64.23 | 8.04B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
695.92 | 86.59B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
285.10 | 55.12B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
133.52 | 32.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
OMI
Owens Minor Inc
|
6.421 | 513.74M | 10.42B | -38.77M | 323.54M | -0.51 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein Medical Announces Winner of Its 2025 Rising Star Award | HSIC Stock News - GuruFocus
Henry Schein Medical Announces Winner of Its 2025 Rising Star Award - Business Wire
Dental Implants and Prosthetics Market Report 2025-2030 - GlobeNewswire
Dental Implants and Prosthetics Market Report 2025-2030 Featuring Institut Straumann AG (Switzerland), Envista (US), Dentsply Sirona (US), Henry Schein, Inc. (US), Osstem Implant Co - Yahoo Finance
Pneumeric, Inc. partners with Henry Schein Medical for distribution of Capnospot - EMS1
UNITED FOOTBALL LEAGUE SELECTS HENRY SCHEIN MEDICAL AS OFFICIAL MEDICAL PRODUCTS SUPPLIER FOR THE 2025 SEASON - The UFL
Henry Schein to Webcast First Quarter 2025 Conference Call on Monday, May 5th, 2025, at 8:00 a.m. ET - Zenopa
Dentsply Sirona downgraded by Morgan Stanley as Canadian banks split on Henry Schein - Oral Health Group
Henry Schein, Inc. (HSIC) Announces New Executive Severance and Change in Control Plans - GuruFocus
Henry Schein sets new executive severance terms By Investing.com - Investing.com South Africa
Henry Schein Adopts New Executive Severance Plan - TipRanks
Henry Schein sets new executive severance terms - Investing.com
Henry Schein to Pay Up to $4,000 – See If You’re Eligible for This Data Breach Settlement! - IDOLGU News
Is The Market Rewarding Henry Schein, Inc. (NASDAQ:HSIC) With A Negative Sentiment As A Result Of Its Mixed Fundamentals? - simplywall.st
$4,000 Settlement for Data Breach Victims – Were You Affected by Henry Schein? - upexciseportal.in
Henry Schein Medical to present EMS solutions at FDIC International 2025 - Fire & Safety Journal Americas
Pneumeric, Inc. Partners with Henry Schein Medical for Distribution of Capnospot® to Its Emergency Medical Services Customers - PRWeb
Evercore ISI Adjusts Price Target on Henry Schein to $68 From $78, Maintains In Line Rating - marketscreener.com
Henry Schein Schedules Earnings Webcast Event - Dentistry Today
Henry Schein Received Validation of Net-Zero Science-Based Targets - Zenopa
Science Based Targets Initiative Validates Henry Schein’s Net-Zero Plan - Orthodontic Products
Henry Schein Sets Science-Based Emissions Reduction Targets for 2030 and 2050 - MarketScreener
Major ESG Milestone: Henry Schein Locks 42% Emissions Cut Target with SBTi Validation - Stock Titan
Henry Schein stock hits 52-week low at $63.66 - Investing.com India
Henry Schein Donations Support Special Olympics Healthy Athletes Screenings at Winter Games in Italy - Dentistry Today
Prudential Financial Inc. Sells 10,083 Shares of Henry Schein, Inc. (NASDAQ:HSIC) - MarketBeat
Henry Schein Will Showcase a Selection of the Company’s Comprehensive Solutions for Oral Health Professionals at the 2025 International Dental Show - Zenopa
Henry Schein Medical to Spotlight Latest EMS Innovations at FDIC International - Firefighter Nation
Is Henry Schein Stock Underperforming the Nasdaq? - Nasdaq
Is Henry Schein Stock Underperforming The Nasdaq? - Barchart.com
IntelePeer Joins Henry Schein One API Exchange as an Authorized Integration Vendor - Bluefield Daily Telegraph
We Think Henry Schein (NASDAQ:HSIC) Can Stay On Top Of Its Debt - simplywall.st
Why Is Henry Schein (HSIC) Down 3.9% Since Last Earnings Report? - Yahoo Finance
Jefferies Adjusts Price Target on Henry Schein to $78 From $87, Keeps Hold Rating - MarketScreener
Is Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Price Struggling As A Result Of Its Mixed Financials? - Yahoo Finance
Mizuho cuts Henry Schein stock price target to $76 from $78 - Investing.com Australia
Mizuho cuts Henry Schein stock price target to $76 from $78 By Investing.com - Investing.com South Africa
Mizuho Adjusts Price Target on Henry Schein to $76 From $78, Maintains Neutral Rating - MarketScreener
Digital Revolution: Henry Schein's 3-Click Dentistry Transforms Oral Health Practice at IDS 2025 - Stock Titan
Henry Schein deal cleared by UK regulators - Newsday
Insider Sell: Philip Laskawy Sells Shares of Henry Schein Inc (H - GuruFocus.com
Major Henry Schein Stock Sales by Top Executives! - TipRanks
Henry Schein CEO Bradford Connett sells $287,161 in stock By Investing.com - Investing.com South Africa
Henry Schein director Philip Laskawy sells $184,998 in stock - Investing.com
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
3.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):